Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page adds recruitment-closure notice and new user help sections, and updates the Intervention/Treatment heading and revision version to v3.6.0.SummaryDifference0.2%

- Check18 days agoChange DetectedAdded revision tag v3.5.5 and removed v3.5.4, updating the page's revision history to reflect a new metadata update rather than changes to study content.SummaryDifference0.0%

- Check39 days agoChange DetectedA new Revision: v3.5.4 was added to the page, and the previous Revision: v3.5.3 along with sponsor/contact lines (AstraZeneca, the Cancer Study Locator phone and email) and a 'Helpful Links Provided by' label were removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site or release maintenance update rather than a change to the study record.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded Naples, Italy, 80131 and removed Napoli, Italy, 80131 from the study locations.SummaryDifference0.0%

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.